158 related articles for article (PubMed ID: 21824269)
21. Glucagon receptor signaling is essential for control of murine hepatocyte survival.
Sinclair EM; Yusta B; Streutker C; Baggio LL; Koehler J; Charron MJ; Drucker DJ
Gastroenterology; 2008 Dec; 135(6):2096-106. PubMed ID: 18809404
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
Cui X; Feng J; Wei T; Zhang L; Lang S; Yang K; Yang J; Liu J; Sterr M; Lickert H; Wei R; Hong T
Diabetologia; 2023 Mar; 66(3):535-550. PubMed ID: 36331598
[TBL] [Abstract][Full Text] [Related]
23. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.
Conarello SL; Jiang G; Mu J; Li Z; Woods J; Zycband E; Ronan J; Liu F; Roy RS; Zhu L; Charron MJ; Zhang BB
Diabetologia; 2007 Jan; 50(1):142-50. PubMed ID: 17131145
[TBL] [Abstract][Full Text] [Related]
24. High-fidelity
Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
[TBL] [Abstract][Full Text] [Related]
25. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
Longuet C; Robledo AM; Dean ED; Dai C; Ali S; McGuinness I; de Chavez V; Vuguin PM; Charron MJ; Powers AC; Drucker DJ
Diabetes; 2013 Apr; 62(4):1196-205. PubMed ID: 23160527
[TBL] [Abstract][Full Text] [Related]
26. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
[TBL] [Abstract][Full Text] [Related]
27. Glucagon receptor inactivation leads to α-cell hyperplasia in zebrafish.
Li M; Dean ED; Zhao L; Nicholson WE; Powers AC; Chen W
J Endocrinol; 2015 Nov; 227(2):93-103. PubMed ID: 26446275
[TBL] [Abstract][Full Text] [Related]
28. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.
Islam D; Zhang N; Wang P; Li H; Brubaker PL; Gaisano HY; Wang Q; Jin T
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E174-81. PubMed ID: 18854429
[TBL] [Abstract][Full Text] [Related]
29. Diversification of the functions of proglucagon and glucagon receptor genes in fish.
Irwin DM; Mojsov S
Gen Comp Endocrinol; 2018 May; 261():148-165. PubMed ID: 29510149
[TBL] [Abstract][Full Text] [Related]
30. Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes.
Ali S; Drucker DJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E415-21. PubMed ID: 19116373
[TBL] [Abstract][Full Text] [Related]
31. Glucagon and glucagon-like peptides 1 and 2.
Holst JJ
Results Probl Cell Differ; 2010; 50():121-35. PubMed ID: 19960378
[TBL] [Abstract][Full Text] [Related]
32. Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia.
Rivero-Gutierrez B; Haller A; Holland J; Yates E; Khrisna R; Habegger K; Dimarchi R; D'Alessio D; Perez-Tilve D
Mol Metab; 2018 Nov; 17():28-38. PubMed ID: 30170980
[TBL] [Abstract][Full Text] [Related]
33. Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.
Okamoto H; Cavino K; Na E; Krumm E; Kim SY; Cheng X; Murphy AJ; Yancopoulos GD; Gromada J
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2753-2758. PubMed ID: 28115707
[TBL] [Abstract][Full Text] [Related]
34. Expression, purification and preliminary characterization of glucagon receptor extracellular domain.
Wu L; Zhai Y; Lu J; Wang Q; Sun F
Protein Expr Purif; 2013 Jun; 89(2):232-40. PubMed ID: 23597780
[TBL] [Abstract][Full Text] [Related]
35. Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.
Zhou C; Dhall D; Nissen NN; Chen CR; Yu R
Pancreas; 2009 Nov; 38(8):941-6. PubMed ID: 19657311
[TBL] [Abstract][Full Text] [Related]
36. Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals.
Irwin DM
Front Endocrinol (Lausanne); 2021; 12():700066. PubMed ID: 34322093
[TBL] [Abstract][Full Text] [Related]
37. Partial ablation of leptin signaling in mouse pancreatic α-cells does not alter either glucose or lipid homeostasis.
Tudurí E; Denroche HC; Kara JA; Asadi A; Fox JK; Kieffer TJ
Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E748-55. PubMed ID: 24473435
[TBL] [Abstract][Full Text] [Related]
38. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.
Lee Y; Wang MY; Du XQ; Charron MJ; Unger RH
Diabetes; 2011 Feb; 60(2):391-7. PubMed ID: 21270251
[TBL] [Abstract][Full Text] [Related]
39. Crispr-Cas9 mediated complete deletion of glucagon receptor in mice display hyperglucagonemia and α-cell hyperplasia.
Yuan H; Kang Q; Li Z; Bai X; Jia J; Han D; Wu X; Li M
Biochem Biophys Res Commun; 2023 Feb; 643():121-128. PubMed ID: 36596263
[TBL] [Abstract][Full Text] [Related]
40. Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations.
Sipos B; Sperveslage J; Anlauf M; Hoffmeister M; Henopp T; Buch S; Hampe J; Weber A; Hammel P; Couvelard A; Höbling W; Lieb W; Boehm BO; Klöppel G
J Clin Endocrinol Metab; 2015 May; 100(5):E783-8. PubMed ID: 25695890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
